ma.nascimento

TL2 · Konya

Contributes reviews on supplier material. Based in Konya.

Joined 18 September 2025 · last posted just now

93 posts, newest first. Showing up to 150.

Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #103 · Practice › Administration · 28 Jul 2026 · 0 likes Building on post #102 rather than restating it. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order,…
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #33 · Lounge › Off topic · 25 Jul 2026 · 25 likes Something I have wondered without ever asking: is there a good reason the vocabulary in this field is so inconsistent between suppliers? Half the disagreements here…
What is genuinely unknown about long-term amylin agonism Replied, post #55 · Compounds › Cagrilintide & amylin analogues · 19 Jul 2026 · 3 likes Post #53 put the caveat in the right place and I want to underline it. Research-use-only cagrilintide is not approved for human use and the published evidence base is a…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #120 · Evidence › Journal club · 14 Jul 2026 · 2 likes No disagreement from me. Posting only so the question does not look ignored.
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #53 · Practice › Dosing & titration · 10 Jul 2026 · 7 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose. I…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #59 · Analytics › Impurities & related substances · 8 Jul 2026 · 0 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
A critique that turned out to be unfair, retracted by its author Replied, post #25 · Evidence › Study critique · 6 Jul 2026 · 9 likes Seconded. It reads as careful rather than confident, which is the right register.
A comparison of home results against a laboratory result on the same vial — does this… Replied, post #6 · Analytics › Home & field testing · 2 Jul 2026 · 0 likes The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
Tracking a shortage from primary sources rather than rumour Replied, post #77 · Access › Shortages · 30 Jun 2026 · 0 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
NHS criteria and how they are applied in practice Replied, post #9 · Regional › UK & Ireland · 23 Jun 2026 · 27 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Journal club: what we got wrong in an earlier session Replied, post #21 · Evidence › Journal club · 22 Jun 2026 · 6 likes Useful. I had the fact and not the reason, which turns out to be the important half.
I joined for one answer and stayed for a year — what changed my mind Replied, post #32 · Start Here › Welcome · 20 Jun 2026 · 9 likes The answer to the reading-order question is: the how-to-ask page, then whichever compound page applies to you, then the sourcing standard. Forty minutes and it saves…
What steady state means for the decision to escalate Replied, post #16 · Practice › Dosing & titration · 19 Jun 2026 · 0 likes That is a cleaner way of putting what I was circling around.
Electrolyte supplements: which ones do anything Replied, post #29 · Nutrition & Training › Hydration & electrolytes · 12 Jun 2026 · 19 likes Narrowing post #27, because the general version has more than one answer. Where there is a genuine question, a measurement answers it and a supplement does not. Blood…
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #5 · Compounds › Cagrilintide & amylin analogues · 6 Jun 2026 · 15 likes The phase 3 combination programme is where the clinically interesting numbers will come from. Phase 2 established that the combination does something; the size of it in…
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #59 · Practice › Storage & stability · 2 Jun 2026 · 0 likes Post #57 is right about the mechanism and I think understates the practical bit. Counterpoint on Mean kinetic temperature, offered without confidence: the same…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #66 · Practice › Reconstitution · 31 May 2026 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #46 · Safety › Contraindications · 22 May 2026 · 0 likes I read post #42 twice before replying, because I had assumed the opposite. Somebody's condition being on a list does not settle the decision, and somebody's condition…
Prescription requirements and telehealth models — a second dataset Replied, post #27 · Sourcing › Regulatory · 12 May 2026 · 16 likes Taking post #24 at face value and following it one step further. The confident answers on Prescription requirements and telehealth models and the well-sourced answers…
Anaesthesia and elective surgery: the aspiration question Replied, post #97 · Practice › Interactions · 23 Apr 2026 · 5 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #9 · Analytics › Method validation · 21 Apr 2026 · 28 likes Post #5 and I disagree about the size of the effect, not about the direction. Forced degradation under acid, base, oxidation, heat and light is how specificity is…
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #52 · Evidence › Trials · 20 Apr 2026 · 1 like Confirming post #51 from a second method, which matters more than confirming it from a second person. Absolute and relative effects answer different questions. Write…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #114 · Clinical › Bloodwork · 29 Mar 2026 · 17 likes What I would tell a new member reading about panel for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #56 · Research Methods › N-of-1 designs · 19 Mar 2026 · 7 likes A photograph or a device reading is a harder record than a recollection, and where one is available it should be the record.
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #94 · Lounge › Introductions · 17 Mar 2026 · 6 likes Clinician voices are genuinely welcome and are asked to be explicit about the line. Several members here say plainly in every post that they are describing general…
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #55 · Practice › Storage & stability · 4 Mar 2026 · 4 likes Trying to state the Adsorptive losses position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #128 · Compounds › Semaglutide · 24 Feb 2026 · 12 likes Worth separating two things that post #126 runs together. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #53 · Sourcing › Regulatory · 26 Jan 2026 · 17 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post.
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #32 · Start Here › Welcome · 17 Jan 2026 · 0 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most. I…
A partial dose because the pen emptied mid-injection Replied, post #33 · Practice › Administration · 8 Jan 2026 · 1 like Taking post #32 at face value and following it one step further. I would rather this thread reach "we do not know" about partial dose because the pen than reach a…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #11 · Practice › Side effects · 1 Jan 2026 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Second pass at: The topic list is dense — is that deliberate? Replied, post #28 · Meta › Site feedback · 25 Dec 2025 · 0 likes Before the thread moves on from topic list — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four…
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #2 · Practice › Storage & stability · 15 Dec 2025 · 20 likes Published stability data covers a specific formulation at a specific concentration in a specific container. A home-reconstituted preparation matches none of those, and…
Tracking a preprint to publication: a worked example Replied, post #112 · Evidence › Preprints · 11 Dec 2025 · 15 likes Seconded. It reads as careful rather than confident, which is the right register.
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #35 · Documentation › Doc review · 30 Nov 2025 · 0 likes Post #34 is right about the mechanism and I think understates the practical bit. What I can speak to on evidence digest is narrow, so I will keep it narrow rather than…
Why "add 2 mL" is not an instruction Replied, post #10 · Practice › Reconstitution · 22 Nov 2025 · 6 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. This is the…
What a purity-only report leaves out Replied, post #88 · Sourcing › Independent verification · 15 Nov 2025 · 11 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. Nothing above should be read as advice about what…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #5 · Data & Tools › Calculators · 10 Nov 2025 · 4 likes Worth separating two things that the opening post runs together. My experience of Feature request contradicts the reply above. I am posting it as a data point rather…
Lyophilisation and why the cake looks the way it does Replied, post #20 · Pharmacology › Formulation chemistry · 13 Oct 2025 · 0 likes My experience of lyophilisation contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
Documentation that appears only after payment Replied, post #27 · Sourcing › Red flags · 17 Sep 2025 · 4 likes Useful. I have added it to my own notes with the date on it.
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #105 · Evidence › Study critique · 16 Sep 2025 · 0 likes What would change my mind on Reverse causation is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say…
Payment method and the leverage it gives you, ranked Replied, post #11 · Sourcing › Payments · 14 Sep 2025 · 0 likes I had written a reply contradicting post #9 and deleted it. Here is what survived. Escrow services: some third-party services hold payment until the buyer confirms…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #20 · Evidence › Study critique · 12 Sep 2025 · 0 likes Noted, and thank you for writing it out rather than summarising it.
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #26 · Analytics › Method validation · 1 Sep 2025 · 8 likes Worth separating two things that post #24 runs together. Why two laboratories may disagree: after validating the same method, they may still report different purity on…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #56 · Practice › Side effects · 27 Aug 2025 · 1 like The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Coming back to: Why quantitation is the hard part, not detection Replied, post #56 · Analytics › Home & field testing · 26 Aug 2025 · 17 likes Quantitation looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #83 · Sourcing › Regulatory · 18 Aug 2025 · 8 likes Trying to state the compound being unapproved position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread…
Immortal time bias in a claims-database study Replied, post #24 · Evidence › Study critique · 18 Aug 2025 · 0 likes A criticism that would apply equally to every trial in the field is worth stating once and is not a reason to discount a particular paper. That is what the…
Which panel is worth repeating and which is worth ignoring Replied, post #87 · Clinical › Bloodwork · 17 Aug 2025 · 32 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #33 · Analytics › HPLC & UHPLC · 15 Aug 2025 · 20 likes I would put moderate confidence on the mainstream reading of detection wavelength and no more. That is not scepticism for its own sake; it is where the sourcing…
Are there stupid questions here? A staff answer, at length Replied, post #51 · Start Here › Welcome · 8 Aug 2025 · 15 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Travel coolers and how long they really hold Replied, post #56 · Devices › Cold chain · 5 Aug 2025 · 8 likes Adding the measurement that post #54 says would settle it. I would call the community position on travel coolers likely rather than established, and I would be…
Coming back to: Cross-border purchase rules within the EU Replied, post #15 · Regional › European Union · 4 Aug 2025 · 6 likes Practical note on Cross-border purchase rules within: write down what you expect before you look. The number of times I have found what I went looking for is higher…
Titles that describe the question, not the situation Replied, post #53 · Start Here › How to Ask · 21 Jul 2025 · 4 likes Confirming post #51 from a second method, which matters more than confirming it from a second person. Source for the titles figure, since it was asked for. It is in the…
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #28 · Compounds › Cagrilintide & amylin analogues · 8 Jul 2025 · 19 likes Clear enough that I do not think I have a follow-up, which is unusual.
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #57 · Compounds › Oral incretins · 2 Jul 2025 · 4 likes Orforglipron is a small molecule rather than a peptide, which changes almost everything about how it is made, stored and analysed. Comparing it to oral semaglutide as…
An emergency department visit, described afterwards Replied, post #37 · Safety › Adverse events · 1 Jul 2025 · 10 likes Signs of dehydration after repeated vomiting are the most common serious secondary problem described here and are also the most preventable. Not a conclusion. A place…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #134 · Practice › Reconstitution · 13 Jun 2025 · 9 likes Adding a null result on 5 mg vial. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
Journal club: SURMOUNT-1, read without the press release Replied, post #132 · Evidence › Journal club · 7 Jun 2025 · 0 likes Post #131 is right about the mechanism and I think understates the practical bit. SURMOUNT-1 is a good example of a question where the honest answer is boring and the…
Antibiotics and a course of something with delayed emptying Replied, post #54 · Practice › Interactions · 31 May 2025 · 2 likes Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #27 · Compounds › Repair & healing peptides · 31 May 2025 · 1 like Helpful, and easy to find again, which is half of what a good reply is.
A supplier that answers analytical questions with restated claims Replied, post #85 · Sourcing › Red flags · 28 May 2025 · 0 likes This follows post #82 rather than contradicting it. Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way…
Validating a calculator against hand arithmetic — what changed since Replied, post #95 · Data & Tools › Calculators · 27 May 2025 · 11 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
Pregnancy as an absolute contraindication Replied, post #101 · Safety › Contraindications · 20 May 2025 · 7 likes Where a contraindication is relative rather than absolute, the reasoning usually appears in the assessment report rather than the labelling. That holds for the case as…
Requesting a translation of an existing page Replied, post #18 · Documentation › Wiki requests · 17 May 2025 · 14 likes Everything in post #14 holds. The case it does not cover is the one I have. Review cadence should be part of the proposal. A page about a fast-moving area needs a…
Publishing an inconvenient result: a case study Replied, post #19 · Sourcing › Independent verification · 13 May 2025 · 0 likes Adding a small correction to the publishing an inconvenient result summary above rather than a disagreement with it. The substance holds; one of the figures is out by a…
A well-designed study with a badly written abstract Replied, post #53 · Evidence › Study critique · 30 Apr 2025 · 3 likes Post #49 and I disagree about the size of the effect, not about the direction. Generalisability and validity are separate axes. A trial can be internally impeccable and…
Metformin co-administration and additive GI effects Replied, post #19 · Practice › Interactions · 28 Apr 2025 · 0 likes That is a cleaner way of putting what I was circling around.
Follow-up: Documentation that appears only after payment Replied, post #4 · Sourcing › Red flags · 17 Apr 2025 · 30 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #36 · Compounds › Tirzepatide · 7 Apr 2025 · 1 like I would keep GIP component of tirzepatide and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #158 · Sourcing › Regulatory · 6 Mar 2025 · 28 likes A compound in a compounding pathway in one country and unavailable in another is a common situation and produces most of the confusion here.
Pharmaceutical compounding rules, summarised from primary sources Replied, post #118 · Sourcing › Regulatory · 4 Mar 2025 · 2 likes Post #115 is the version of this I will quote in future. One addition. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is…
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #41 · Documentation › Doc review · 27 Feb 2025 · 0 likes Confirming post #39 from a second method, which matters more than confirming it from a second person. Recording a dissent would be much easier to settle if anyone…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #66 · Compounds › Other compounds · 17 Jan 2025 · 0 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
UK access routes, dated and sourced — a second dataset Replied, post #25 · Regional › UK & Ireland · 10 Jan 2025 · 13 likes Narrowing post #23, because the general version has more than one answer. A dated first-hand account of a specific route is genuinely useful in this subcategory and…
[2026 update] New subcategory: rationale and scope Replied, post #125 · Meta › Announcements · 6 Jan 2025 · 7 likes Nobody has said the unglamorous part of New subcategory yet, so: most of the variation is explained by things that are boring to write about and easy to check.
Building a sensible monitoring schedule with your prescriber Replied, post #25 · Clinical › Bloodwork · 19 Dec 2024 · 31 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
Pregnancy as an absolute contraindication — the long version Started this topic · Safety › Contraindications · 8 Dec 2024 · 14 likes On the subject in the title: Pregnancy as an absolute contraindication — the long version Working notes rather than a conclusion. A narrow question about Pregnancy,…
Washout with a one-week half-life: the arithmetic Replied, post #37 · Research Methods › N-of-1 designs · 29 Nov 2024 · 5 likes Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met).…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #43 · Clinical › Special populations · 23 Nov 2024 · 0 likes I think the Type 1 diabetes question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Revisiting: Moderation log format change Replied, post #23 · Meta › Announcements · 10 Nov 2024 · 0 likes I had written a reply contradicting post #21 and deleted it. Here is what survived. Where I have landed on Moderation log format change, having got it wrong once in…
Time to steady state after a dose increase Replied, post #90 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 0 likes Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration, assay sensitivity and population all move the…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #125 · Clinical › Comorbidities · 29 Oct 2024 · 0 likes I had written a reply contradicting post #124 and deleted it. Here is what survived. Taking Hypertension improvement seriously for a moment rather than deflecting: the…
Requesting a page: what makes a good request — what changed since Replied, post #122 · Documentation › Wiki requests · 13 Oct 2024 · 20 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #97 · Clinical › Bloodwork · 10 Oct 2024 · 5 likes Post #96 is the version of this I will quote in future. One addition. A trend needs at least three points to be a trend. Two points are a line and a line through noise…
Why I ask for the gradient before I discuss the number Replied, post #21 · Analytics › HPLC & UHPLC · 18 Sep 2024 · 12 likes Change the wavelength and the proportions change even though the sample has not. That is the reason the wavelength has to be on the document for the number to mean…
Pen wastage and its effect on real cost Replied, post #21 · Access › Pricing · 2 Sep 2024 · 11 likes Post #17 and I disagree about the size of the effect, not about the direction. A cheaper option that arrives slowly has a cost in the form of running out, and people…
Progressive overload when the scale is falling — one year on Replied, post #17 · Nutrition & Training › Resistance training · 31 Aug 2024 · 30 likes One caution on Progressive overload: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Started this topic · Sourcing › Independent verification · 14 Aug 2024 · 1 like Posting this under the heading it deserves: Splitting a vial for two laboratories: how to do it without ruining both — what changed since Everything below is what sits…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #40 · Practice › Dosing & titration · 6 Aug 2024 · 28 likes I have no financial interest in anything named in this thread and I want to say so before I comment on four-week escalation interval, because it is the sort of subject…
Reporting a discrepancy without making an allegation Replied, post #11 · Sourcing › Vendor reports · 1 Aug 2024 · 9 likes Second-hand on reporting a discrepancy, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
The mass-error checker and its intended scope Replied, post #144 · Data & Tools › Calculators · 22 Jul 2024 · 0 likes The calculators maintained on this site are open-source and verifiable. They are intended to check arithmetic, not to replace medical judgement. Using them is optional…
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #17 · Nutrition & Training › Resistance training · 24 Jun 2024 · 0 likes Confirming post #16 from a second method, which matters more than confirming it from a second person. The reports here that state the programme, the load and the…